7.5mg tablets

15mg tablets are  not approved

Sodium hydrogen carbonate 500mg, sodium dihydrogen phosphate 680mg  - Lecicarbon A® Suppository

• Pre-operative use for patients undergoing rectal surgery or diagnostic procedure  
• 2nd/3rd line in spinal injuries after bisacodyl and glycerol rectal have been tried.  

• For use as a second line agent in paediatric patients with constipation when Movicol, lactulose and senna are ineffective as single agent therapy.

• Note: Co-danthramer and Co-danthrusate are generally restricted to use in the treatment of constipation in terminally ill patients. A combination of Senna and Docusate is normally preferred.

• Note: Co-danthramer and Co-danthrusate are generally restricted to use in the treatment of constipation in terminally ill patients. A combination of Senna and Docusate is normally preferred.

Limited evidence of effectiveness. 

For consideration in palliative care, see regional Palliative and End of Life Care guidance (link below)